XML 135 R113.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity (Statement) - USD ($)
$ in Thousands
Common Stock
Private Placement
Common Stock
Additional paid-in capital
Private Placement
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Private Placement
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Private Placement
Cumulative Effect, Period of Adoption, Adjustment
Total
Beginning balance at Dec. 31, 2017       $ 377,809 $ (18,540)   $ (379) $ (309,576)   $ (379) $ 52,167
Net income               142,112     142,112
Other comprehensive (loss) income, net of taxes         (10,874)           (10,874)
Dividends declared (Note 13)               (20,005)     (20,005)
Shares issued in connection with deferred compensation plan, net               (6,884)     (6,861)
Deferred compensation plan voluntary contributions       4,504             4,504
Payment of shareholder Put and Call rights               (8,560)     (8,571)
Common Stock Purchase Agreement, net       13       (9,673)     (9,673)
Stock option exercises, net       2,151       (1,569)     610
Stock-based compensation expense       7,882             7,882
Shares related to restricted stock, net       494       (637)     (137)
Other       43             43
Ending balance (in shares) at Dec. 31, 2018   250,283,513                  
Ending balance at Dec. 31, 2018   $ 2,502   392,896 (29,414)   107,822 (218,553)   107,822 147,431
Net income               66,845     66,845
Other comprehensive (loss) income, net of taxes         5,778           5,778
Dividends declared (Note 13)               (19,023)     (19,023)
Profit -sharing plan shares, net (in shares)   (258,103)                  
Profit sharing plan shares, net   $ (3)           (1,936)     (1,939)
Shares issued in connection with deferred compensation plan, net (in shares)   2,233,807                  
Shares issued in connection with deferred compensation plan, net   $ 22           (4,994)     (4,972)
Deferred compensation plan voluntary contributions       2,664             2,664
Payment of shareholder Put and Call rights (in shares)   (632,859)                  
Payment of shareholder Put and Call rights   $ (6)           (4,946)     (4,952)
Common Stock Purchase Agreement, net (in shares) 64,509                    
Common Stock Purchase Agreement, net $ 1   $ 466     $ (47)     $ 420    
Stock option exercises, net (in shares)   2,979,031                  
Stock option exercises, net   $ 30   3,009       (2,255)     784
Stock-based compensation expense       6,046             6,046
Shares related to restricted stock, net (in shares)   402,250                  
Shares related to restricted stock, net   $ 4   (4)       (344)     (344)
Other (in shares)   5,290                  
Other       40       (17)     23
Ending balance (in shares) at Sep. 30, 2019   255,077,438                  
Ending balance at Sep. 30, 2019   $ 2,550   405,117 (23,636)     (77,448)     306,583
Beginning balance (in shares) at Dec. 31, 2018   250,283,513                  
Beginning balance at Dec. 31, 2018   $ 2,502   392,896 (29,414)   107,822 (218,553)   107,822 147,431
Net income               103,096     103,096
Other comprehensive (loss) income, net of taxes         5,487           5,487
Dividends declared (Note 13)               (25,390)     (25,390)
Shares issued in connection with deferred compensation plan, net               (5,632)     (5,609)
Deferred compensation plan voluntary contributions       3,586             3,586
Payment of shareholder Put and Call rights               (8,827)     (8,838)
Common Stock Purchase Agreement, net       466       (48)     418
Stock option exercises, net       3,579       (2,309)     1,303
Stock-based compensation expense       8,091             8,091
Shares related to restricted stock, net       (4)       (399)     (399)
Other       53       (15)     38
Ending balance (in shares) at Dec. 31, 2019   254,842,949                  
Ending balance at Dec. 31, 2019   $ 2,548   408,667 (23,927)   $ 107,822 (52,669)   $ 107,822 334,619
Net income               74,589     74,589
Other comprehensive (loss) income, net of taxes         (5,284)           (5,284)
Dividends declared (Note 13)               (415,748)     (415,748)
Profit -sharing plan shares, net (in shares)   (549,834)                  
Profit sharing plan shares, net   $ (5)           (6,965)     (6,970)
Shares issued in connection with deferred compensation plan, net (in shares)   2,984,531                  
Shares issued in connection with deferred compensation plan, net   $ 30           (1,907)     (1,877)
Deferred compensation plan voluntary contributions       2,602             2,602
Payment of shareholder Put and Call rights (in shares)   (128,176)                  
Payment of shareholder Put and Call rights   $ (1)           (1,453)     (1,454)
Common Stock Purchase Agreement, net (in shares) 169                    
Common Stock Purchase Agreement, net           $ (57)     $ (57)    
Stock option exercises, net (in shares)   3,506,103                  
Stock option exercises, net   $ 35   7,741       (3,618)     4,158
Shares issued for stock grants, net (in shares)   17,411                  
Shares issued for stock grants, net       219             219
Stock-based compensation expense       22,510             22,510
Shares related to restricted stock, net (in shares)   1,553,883                  
Shares related to restricted stock, net   $ 15   (16)       (133)     (134)
Ending balance (in shares) at Sep. 30, 2020   262,227,036                  
Ending balance at Sep. 30, 2020   $ 2,622   $ 441,723 $ (29,211)     $ (407,961)     $ 7,173